DPP-IV inhibitors can improve glucose regulation being helpful for type 2 diabetes, antioxidant could prevent cells damage by reducing the production of reactive oxygen species, DPP III inhibitors could exert opioid activity [63], and TPP II inhibitors may contribute to antitumor activity [64]. This evidence concerns the gene DPP3 and type 2 diabetes mellitus.